These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1639576)

  • 1. Bovine babesiosis: failure to induce interferon gamma production in response to Babesia bovis antigens in cattle.
    Orinda GO; Gale KR; Wright IG; Parrodi F
    Int J Parasitol; 1992 May; 22(3):395-8. PubMed ID: 1639576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Babesia bovis: characterization of the T helper cell response against the 42-kDa merozoite surface antigen (MSA-1) in cattle.
    Brown WC; Palmer GH; McElwain TF; Hines SA; Dobbelaere DA
    Exp Parasitol; 1993 Aug; 77(1):97-110. PubMed ID: 8344411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunisation of cattle against Babesia bovis combining a multi-epitope modified vaccinia Ankara virus and a recombinant protein induce strong Th1 cell responses but fails to trigger neutralising antibodies required for protection.
    Jaramillo Ortiz JM; Paoletta MS; Gravisaco MJ; López Arias LS; Montenegro VN; de la Fournière SAM; Valenzano MN; Guillemi EC; Valentini B; Echaide I; Farber MD; Wilkowsky SE
    Ticks Tick Borne Dis; 2019 Oct; 10(6):101270. PubMed ID: 31445874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of T-helper cell gamma interferon and immunoglobulin G responses specific for Babesia bovis rhoptry-associated protein 1 (RAP-1) or a RAP-1 protein lacking the carboxy-terminal repeat region is insufficient to provide protective immunity against virulent B. bovis challenge.
    Norimine J; Mosqueda J; Suarez C; Palmer GH; McElwain TF; Mbassa G; Brown WC
    Infect Immun; 2003 Sep; 71(9):5021-32. PubMed ID: 12933845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of a recombinant MSA-2c-based ELISA to establish the persistence of antibodies in cattle vaccinated with Babesia bovis.
    Bono MF; Mangold AJ; Baravalle ME; Valentini BS; Thompson CS; Wilkowsky SE; Echaide IE; Farber MD; Torioni de Echaide SM
    Vet Parasitol; 2008 Nov; 157(3-4):203-10. PubMed ID: 18783887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis.
    Patarroyo JH; Prates AA; Tavares CA; Mafra CL; Vargas MI
    Vet Parasitol; 1995 Oct; 59(3-4):189-99. PubMed ID: 8533277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for recombinant vaccines against Babesia bovis and related parasites.
    Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
    Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate vaccine antigens of bovine hemoparasites Theileria parva and Babesia bovis by use of helper T cell clones.
    Brown WC; Zhao S; Logan KS; Grab DJ; Rice-Ficht AC
    Vet Parasitol; 1995 Mar; 57(1-3):189-203. PubMed ID: 7597783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune control of Babesia bovis infection.
    Brown WC; Norimine J; Knowles DP; Goff WL
    Vet Parasitol; 2006 May; 138(1-2):75-87. PubMed ID: 16510249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Babesia bovis: analysis of and preliminary vaccination studies with a defined infected erythrocyte membrane binding antigen.
    Goodger BV; Waltisbuhl DJ; Wright IG; White M
    Int J Parasitol; 1992 Jul; 22(4):533-5. PubMed ID: 1644530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Babesia bovis and B. bigemina: Persistence of infection in friesian cows following vaccination with live antibabesial vaccines.
    Pipano E; Shkap V; Kriegel Y; Leibovitz B; Savitsky I; Fish L
    Vet J; 2002 Jul; 164(1):64-8. PubMed ID: 12359486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against Babesia bovis: T cells from protected and unprotected animals show different cytokine profiles.
    East IJ; Zakrzewski H; Gale KR; Leatch G; Dimmock CM; Thomas MB; Waltisbuhl DJ
    Int J Parasitol; 1997 Dec; 27(12):1537-45. PubMed ID: 9467739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of cattle against B. bovis infection with live attenuated parasites and non-viable immunogens.
    Fish L; Leibovich B; Krigel Y; McElwain T; Shkap V
    Vaccine; 2008 Dec; 26 Suppl 6():G29-33. PubMed ID: 19178890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an Australian Babesia bovis vaccine strain in Malawi.
    Lawrence JA; Malika J; Whiteland AP; Kafuwa P
    Vet Rec; 1993 Mar; 132(12):295-6. PubMed ID: 8470344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular approaches to elucidating innate and acquired immune responses to Babesia bovis, a protozoan parasite that causes persistent infection.
    Brown WC
    Vet Parasitol; 2001 Nov; 101(3-4):233-48. PubMed ID: 11707299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological responses to Babesia bovis vaccination in cattle previously infected with Babesia bigemina.
    Combrink MP; Troskie PC; Du Plessis F; Latif AA
    Vet Parasitol; 2010 May; 170(1-2):30-6. PubMed ID: 20207488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel 20-kilodalton protein conserved in Babesia bovis and B. bigemina stimulates memory CD4(+) T lymphocyte responses in B. bovis-immune cattle.
    Brown WC; Ruef BJ; Norimine J; Kegerreis KA; Suarez CE; Conley PG; Stich RW; Carson KH; Rice-Ficht AC
    Mol Biochem Parasitol; 2001 Nov; 118(1):97-109. PubMed ID: 11704278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Babesia bovis merozoite surface protein-2c (MSA-2c) contains highly immunogenic, conserved B-cell epitopes that elicit neutralization-sensitive antibodies in cattle.
    Wilkowsky SE; Farber M; Echaide I; Torioni de Echaide S; Zamorano PI; Dominguez M; Suarez CE; Florin-Christensen M
    Mol Biochem Parasitol; 2003 Apr; 127(2):133-41. PubMed ID: 12672522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine babesiosis: induction of protective immunity with culture-derived Babesia bovis and Babesia bigemina immunogens.
    Montenegro-James S; Toro Benitez M; Leon E; Lopez R; Ristic M
    Parasitol Res; 1987; 74(2):142-50. PubMed ID: 3325981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
    Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
    Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.